Pilatus Biosciences to Present Preclinical Data Highlighting Novel Metabolic Checkpoint Therapy PLT012 at EASL Congress 2026 ...
Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers
Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immune checkpoint inhibitors. Cancer-associated fibroblasts (CAFs) are an important part of the tumor ...
Postdoctoral researcher Fariha Imtiaz at Virginia Commonwealth University studies how dietary advanced glycation end-products ...
Pedro Correa de Sampaio (left) is the CEO and Co-Founder of Neobe (Stevenage, UK), a company engineering microbial trojan horses to carry payloads into solid tumors, which can break down fibrotic ...
Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest moments—revealing how lung cells with cancer-causing mutations recruit ...
Collagen plays dual roles in pancreatic cancer: as a physical fiber that obstructs macromolecular drug delivery, and as a bioactive signaling molecule that activates discoidin domain receptor 1 (DDR1) ...
A new study suggests that Resmetirom may do more than treat fatty liver disease — it could also help stop liver cancer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results